Market Focus Target healthcare facilities and clinics focusing on oncology, women's health, infectious disease, respiratory, and toxicology, highlighting Immunostics’ broad diagnostic portfolio for expanded cross-selling opportunities across these high-need areas.

Strategic Partnerships Leverage past and potential collaborations with research institutions and healthcare providers (example: University of Utah partnership) to co-market and co-develop assays, expanding credibility and opening doors to new hospital systems and labs.

Global Presence Capitalize on participation in international events (such as Medlab Middle East) to generate international leads, distributor partnerships, and multi-region sales through channel expansion.

Product Expansion Promote AFIAS platform portfolio alongside new assays (e.g., COVID-19 Ab test history) to showcase ready-to-deploy diagnostic solutions, enabling faster procurement cycles for labs seeking integrated analyzer-compatible tests.

Growth Signals Note revenue scale and growth potential in a lean organization; position Immunostics as an agile partner for mid-market labs and regional distributors seeking innovative, cost-effective diagnostic solutions and faster time-to-market.